January 27, 2023

Day: November 30, 2022

PRESS RELEASES

IIBA Announces The Business Analysis Standard

IIBA’s Business Analysis Standard is a new resource developed with input from the global business analysis community to address current practice needs TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — The International Institute of Business Analysis™ (IIBA®) is the global association leading the business analysis community and professional standards, so every person achieves more. IIBA® is […]

Read More
PRESS RELEASES

IIBA Announces The Business Analysis Standard

IIBA’s Business Analysis Standard is a new resource developed with input from the global business analysis community to address current practice needs TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — The International Institute of Business Analysis™ (IIBA®) is the global association leading the business analysis community and professional standards, so every person achieves more. IIBA® is […]

Read More
PRESS RELEASES

Aqualia Selects Cority Safety Essentials Solution

Leading European water management company seeks to bolster global health and safety program with integrated digital solution Cority logo TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — Global enterprise EHS (Environmental, Health, and Safety) software provider Cority announced today its partnership with a new customer, Aqualia, a leading global water management company. The Spain-based organization, owned […]

Read More
PRESS RELEASES

Aqualia Selects Cority Safety Essentials Solution

Leading European water management company seeks to bolster global health and safety program with integrated digital solution Cority logo TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — Global enterprise EHS (Environmental, Health, and Safety) software provider Cority announced today its partnership with a new customer, Aqualia, a leading global water management company. The Spain-based organization, owned […]

Read More
PRESS RELEASES

AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma

AUM302 has potential to be the first multi-kinase inhibitor class of drug in Neuroblastoma SINGAPORE and BETHESDA, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) — AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotech company focused on discovering and developing precision oncology therapeutics, announced today that the U.S. Food and Drug Administration (“FDA”) has granted Orphan […]

Read More
PRESS RELEASES

AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma

AUM302 has potential to be the first multi-kinase inhibitor class of drug in Neuroblastoma SINGAPORE and BETHESDA, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) — AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotech company focused on discovering and developing precision oncology therapeutics, announced today that the U.S. Food and Drug Administration (“FDA”) has granted Orphan […]

Read More
PRESS RELEASES

ZeroBounce Launches India Website

Email validation and deliverability company ZeroBounce announces the launch of its India website. The site (zerobounce.in) processes customer data strictly within India, easing concerns about the country’s upcoming privacy laws. ZeroBounce India SANTA BARBARA, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — Email validation and deliverability company ZeroBounce announces the launch of its India website. The […]

Read More
PRESS RELEASES

ZeroBounce Launches India Website

Email validation and deliverability company ZeroBounce announces the launch of its India website. The site (zerobounce.in) processes customer data strictly within India, easing concerns about the country’s upcoming privacy laws. ZeroBounce India SANTA BARBARA, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — Email validation and deliverability company ZeroBounce announces the launch of its India website. The […]

Read More